Onderneming Aoxing Pharmaceutical Company, Inc. Other OTC
Aandelen
AOXG
US03740A1060
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
Narcotics & Pain Management Products
100,0
%
| 25 | 100,0 % | 32 | 100,0 % | +26,88% |
Verkoop per regio
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
Cnina
100,0
%
| 25 | 100,0 % | 32 | 100,0 % | +26,88% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11-08-23 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-01-11 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 76 209 195 | 76 209 195 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
![Adres Aoxing Pharmaceutical Company, Inc.(AOXG)](https://cdn.zonebourse.com/static/address/38481065.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,80% | 43,81 mld. | |
+30,40% | 23,03 mld. | |
+21,32% | 15,45 mld. | |
+19,05% | 14,4 mld. | |
+58,92% | 12,95 mld. | |
-0,05% | 6,79 mld. | |
-11,84% | 6,49 mld. | |
-8,87% | 5,73 mld. | |
+14,11% | 5,49 mld. |